Pfizer postponed the price increases after criticism from President Donald Trump. But the increases are delayed only until next year, and there are no plans to change how Pfizer prices drugs.
“Your apparent agreement with President Trump is exactly why we need transparency and accountability. I call on you to make these price reductions permanent and to reduce prices on other medications that have increased,” Ms. Baldwin wrote.
Ms. Baldwin called on Pfizer executives to consider ending its stock buyback program and use profits and corporate tax cut revenue to cut drug prices. he company also was asked to explain why the price of some products were raised in the first place.
More articles on pharmacy:
Packaging concerns force Novartis, Sandoz to recall 12 drugs
Pfizer stock value dips after Trump’s tweet
8 lesser-known facts about Pfizer
